These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion. Klostermann F; Jugel C; Bömelburg M; Marzinzik F; Ebersbach G; Müller T Mov Disord; 2012 Nov; 27(13):1704-5. PubMed ID: 23192929 [No Abstract] [Full Text] [Related]
7. Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Greene P; Cote L; Fahn S Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214 [No Abstract] [Full Text] [Related]
8. Skin rash associated with Sinemet does not equal levodopa allergy. Chou KL; Stacy MA Neurology; 2007 Mar; 68(13):1078-9. PubMed ID: 17389317 [No Abstract] [Full Text] [Related]
9. [Clinical significance of cramps of the lower extremities in patients with parkinsonism]. Yu HZ Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):217-8. PubMed ID: 4075911 [No Abstract] [Full Text] [Related]
10. Risk factors for motor response complications in L-dopa-treated parkinsonian patients. Peppe A; Dambrosia JM; Chase TN Adv Neurol; 1993; 60():698-702. PubMed ID: 8420213 [No Abstract] [Full Text] [Related]
11. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700 [TBL] [Abstract][Full Text] [Related]
12. First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy. Djaldetti R; Achiron A; Ziv I; Melamed E Mov Disord; 1994 Sep; 9(5):582-3. PubMed ID: 7990855 [No Abstract] [Full Text] [Related]
13. Square-wave action dystonia in Parkinson's disease. van den Munckhof P; Lenz FA; Chase TN Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355 [No Abstract] [Full Text] [Related]
14. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment. Galazky I; Schoof J; Stallforth S; Kupsch A; Heinze HJ; Kluge C Parkinsonism Relat Disord; 2014 Jan; 20(1):125-7. PubMed ID: 24044946 [No Abstract] [Full Text] [Related]
15. Heterotopic ossification following distal radius fractures in a patient with Parkinson disease treated with levodopa-carbidopa. Ifedi BO; Best CM; Reichel LM J Hand Surg Am; 2013 Jun; 38(6):1259-61. PubMed ID: 23707023 [No Abstract] [Full Text] [Related]
16. Trichophagia affects response to duodenal levodopa/carbidopa gel administration. Müller T; Haas T; Lütge S; Marg M; Ehret R Mov Disord; 2012 Apr; 27(4):588-90. PubMed ID: 22287105 [No Abstract] [Full Text] [Related]
17. Dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion: Management inclinical practice. Melgari JM; Salomone G; di Biase L; Marano M; Scrascia F; Di Lazzaro V Parkinsonism Relat Disord; 2015 Mar; 21(3):327-8. PubMed ID: 25595317 [No Abstract] [Full Text] [Related]
18. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Facca A; Sanchez-Ramos J Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153 [No Abstract] [Full Text] [Related]